RT @uveitis1: A review and update on orphan drugs for the treatment of noninfectious #uveitis. https://t.co/RYeVkBL3Qk
A review and update on orphan drugs for the treatment of noninfectious #uveitis. https://t.co/RYeVkBL3Qk
Our experience with IMT meds for #uveitis and difficulties faced using orphan meds off-label: https://t.co/XR5p4X35bS
FDA must approve “on-label” use of current orphan meds faster/ facilitate insurance coverage for #uveitis patients. https://t.co/fI8V9WRikr
A review and update on orphan drugs for the treatment of Noninfectious Uveitis: https://t.co/h8jphSLUAG
RT @AlyssaHowardMD: A review and update on orphan drugs for the treatment of noninfectious uveitis #calcineurin https://t.co/PUwC9AQYiR
RT @AlyssaHowardMD: A review and update on orphan drugs for the treatment of noninfectious uveitis #calcineurin https://t.co/PUwC9AQYiR
A review and update on orphan drugs for the treatment of noninfectious uveitis #calcineurin https://t.co/PUwC9AQYiR
RT @TheDenverGreene: A review and update on orphan drugs for the treatment of noninfectious uveitis #calcineurin https://t.co/PhDgHr0JxN
A review and update on orphan drugs for the treatment of noninfectious uveitis #calcineurin https://t.co/PhDgHr0JxN